Tech Center 1600 • Art Units: 1614 1626 1628 1629 1642 1691
This examiner grants 80% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18523284 | HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS | Non-Final OA | Genentech, Inc. |
| 18569157 | NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR | Non-Final OA | LG CHEM, LTD. |
| 18018999 | Methods for Treating Respiratory Diseases Characterized by Mucus Hypersecretion | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18572741 | Degrader Compounds and Uses Thereof | Non-Final OA | ABBVIE INC. |
| 18024662 | TREATMENT OF VASCULAR EHLERS-DANLOS SYNDROME AND RELATED SYNDROMES | Non-Final OA | The Johns Hopkins University |
| 18568401 | Method for Producing Fluorescent Probe Library Using Solid-Phase Extraction and Method of Measuring Enzyme Activity Using Same | Non-Final OA | RIKEN |
| 18553968 | CITRON KINASE INHIBITORS | Non-Final OA | The Cleveland Clinic Foundation |
| 18256489 | COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF AND AT LEAST ONE LARGE NEUTRAL AMINO ACID AND/OR CATIONIC AMINO ACID OR PRECURSOR THEREOF | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18526010 | METHOD FOR ALLEVIATING UTERINE LEIOMYOMA USING NICOTINAMIDE | Non-Final OA | TAIPEI MEDICAL UNIVERSITY |
| 18347192 | METHODS OF TREATING CYSTIC FIBROSIS USING WITH-NO-LYSINE (WNK) KINASE PATHWAY INHIBITORS | Non-Final OA | UNIVERSITY OF IOWA RESEARCH FOUNDATION |
| 18278526 | METHODS FOR INHIBITING INFLAMMATION AND PROGRESSION OF ATHEROSCLEROTIC PLAQUES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH CEREBRO- AND CARDIO-VASCULAR DISEASE | Non-Final OA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
| 18572676 | DERIVATIVES OF THE PROTECTIN 10S,17S-DIHDA (PDX) AND USE THEREOF AS ANTIVIRAL, ANTI-INFLAMMATORY, AND ANTI-DIABETIC AGENTS | Non-Final OA | UNIVERSITÉ LAVAL |
| 18580864 | COMPOSITIONS COMPRISING OTESECONAZOLE | Non-Final OA | Mycovia Pharmaceuticals, Inc. |
| 18550624 | ANDROGEN RECEPTOR MODULATORS | Non-Final OA | TRUSTEES OF DARTMOUTH COLLEGE |
| 18400508 | PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED HYDROLYSIS OF BROMOCRIPTINE | Non-Final OA | Ceruvia Lifesciences LLC |
| 18395040 | Lipidic Nano-Pharmaceuticals | Non-Final OA | Huxley Health Inc. |
| 18263196 | PREVENTIVE OR THERAPEUTIC AGENT FOR INFLAMMATORY DISORDERS AND/OR PAIN DISORDERS | Non-Final OA | Kyowa Pharma Chemical Co., Ltd. |
| 18525177 | TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF IN A SUBJECT HAVING INFLUENZA AND A COMPLICATION RISK FACTOR | Non-Final OA | Shionogi & Co., Ltd. |
| 18564031 | CAPSAICIN DERIVATIVES IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS | Non-Final OA | aXichem AB |
| 18289438 | COMPOUNDS FOR TARGETING DEGRADATION OF BRUTON'S TYROSINE KINASE | Non-Final OA | C4 THERAPEUTICS, INC. |
| 18501307 | 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF | Non-Final OA | Biosplice Therapeutics, Inc. |
| 18289465 | INSECTICIDAL COMPOSITIONS COMPRISING OF DIAMIDE AND TETRAMIC ACID COMPOUND | Non-Final OA | WILLOWOOD CHEMICALS LIMITED |
| 18289274 | ANTIDEPRESSANT AND ANXIOLYTIC SUBSTITUTED CINNAMAMIDE COMPOUND | Non-Final OA | TASLY PHARMACEUTICAL GROUP CO., LTD. |
| 18550666 | NITROGEN-CONTAINING HETEROCYCLIC KETONES, PREPARATION METHODS AND MEDICINAL USES THEREOF | Non-Final OA | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| 18287885 | IDH MUTANT INHIBITOR AND USE THEREOF | Non-Final OA | WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD. |
| 18287329 | GOLEXANOLONE FOR USE IN THE TREATMENT OF FATIGUE OR COGNITIVE IMPAIRMENT IN LIVER DISEASE PATIENTS | Non-Final OA | Umecrine Cognition AB |
| 18286536 | BORIC ACID DERIVATIVE ACTING AS Beta-LACTAMASE INHIBITOR | Non-Final OA | TUOJIE BIOTECH (SHANGHAI) CO., LTD. |
| 18278063 | S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Non-Final OA | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES |
| 18554241 | COMBINATIONS OF LSD1 INHIBITORS FOR TREATING MYELOID CANCERS | Non-Final OA | ORYZON GENOMICS, S.A. |
| 18285109 | PSILOCYBIN COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING THE SAME | Non-Final OA | Compass Pathfinder Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy